Hillsdale Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-170	Closed	-$5.89K	–	684
2024 Q2	$5.89K	Sell	170 -30	-15%	-$1.04K	﹤0.01%	543
2024 Q1	$5.79K	Buy	+200	New	+$5.79K	﹤0.01%	558
2021 Q1	–	Sell	-41,500	Closed	-$837K	–	653
2020 Q4	$837K	Buy	+41,500	New	+$837K	0.08%	253